These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3131683)

  • 1. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 2. Genentech gets patent protection for tissue plasminogen activator.
    Ezzell C
    Nature; 1988 Jun; 333(6176):790. PubMed ID: 3133565
    [No Abstract]   [Full Text] [Related]  

  • 3. Claims on tissue plasminogen activator.
    Crespi RS
    Nature; 1989 Jan; 337(6205):317-8. PubMed ID: 2492089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPA patent battle rages in United Kingdom.
    Johnston K
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671
    [No Abstract]   [Full Text] [Related]  

  • 5. New battle over TPA.
    Ezzell C
    Nature; 1989 Aug; 340(6233):418. PubMed ID: 2502715
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent office decision puts Genentech out in front.
    Ezzell C
    Nature; 1987 Nov 12-18; 330(6144):97. PubMed ID: 3478596
    [No Abstract]   [Full Text] [Related]  

  • 7. Genentech patent.
    Nature; 1988 Sep; 335(6186):105. PubMed ID: 3137476
    [No Abstract]   [Full Text] [Related]  

  • 8. TPA patent battle continues in court.
    Johnston K
    Nature; 1987 Jun 18-24; 327(6123):546. PubMed ID: 3110620
    [No Abstract]   [Full Text] [Related]  

  • 9. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 10. Genentech stops making TPA.
    Wagner M
    Mod Healthc; 1988 Oct; 18(43):5. PubMed ID: 10325205
    [No Abstract]   [Full Text] [Related]  

  • 11. A footnote to the Cohen-Boyer patent and other musings.
    Goldstein JA
    Recomb DNA Tech Bull; 1982 Dec; 5(4):180-8. PubMed ID: 6962469
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotechnology patents. Genentech wins round two.
    Gershon D
    Nature; 1990 Apr; 344(6268):692. PubMed ID: 2109830
    [No Abstract]   [Full Text] [Related]  

  • 13. First US patent on TPA for Oxford University.
    Ezzell C
    Nature; 1988 Jun; 333(6172):383. PubMed ID: 3131680
    [No Abstract]   [Full Text] [Related]  

  • 14. A nail in the coffin for DNA sequence patents?
    Yamanaka M
    Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining the scope of biotech patent claims.
    McGough KJ
    Biotechnology (N Y); 1995 Apr; 13(4):318-9. PubMed ID: 9678945
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent patent applications in DNA synthesis.
    Nat Biotechnol; 2007 Jun; 25(6):642. PubMed ID: 17557097
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteplase (rtPA) patent case.
    Brahams D
    Lancet; 1988 Nov; 2(8622):1263. PubMed ID: 2904002
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

  • 19. Companies vie over new heart drug.
    Sun M
    Science; 1987 Jul; 237(4811):120-2. PubMed ID: 3110949
    [No Abstract]   [Full Text] [Related]  

  • 20. Genentech falls at the last fence in race to market heart drug.
    Anderson A
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.